1. High rate of profound clonal and renal responses with daratumumab treatment in heavily pre‐treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate. Issue 8 (30th April 2020) Authors: Milani, Paolo; Fazio, Francesca; Basset, Marco; Berno, Tamara; Larocca, Alessandra; Foli, Andrea; Riva, Marcello; Benigna, Francesca; Oliva, Stefania; Nuvolone, Mario; Rodigari, Lara; Petrucci, Maria Teresa; Merlini, Giampaolo; Palladini, Giovanni Journal: American journal of hematology Issue: Volume 95:Issue 8(2020:Aug.) Page Start: 900 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗